World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02878031
Date of registration: 17/08/2016
Prospective Registration: Yes
Primary sponsor: Malaria Consortium
Public title: Community Case Management of Chest Indrawing Pneumonia
Scientific title: Community Case Management of Chest Indrawing Pneumonia With Oral Amoxicillin in Children Aged 2-59 Months Old by Community Oriented Resources Persons (CORPs) in Niger State, Nigeria
Date of first enrolment: October 2016
Target sample size: 191
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02878031
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Nigeria
Contacts
Name:     Karin Kallander, MSc, PhD
Address: 
Telephone:
Email:
Affiliation:  Malaria Consortium
Name:     Ebenezer Baba, MD, MPH
Address: 
Telephone:
Email:
Affiliation:  Malaria Consortium
Key inclusion & exclusion criteria

Inclusion Criteria:

- Chest indrawing pneumonia

Exclusion Criteria:

- Convulsions

- Cough for 14 days or more

- Blood in stool

- Fever for last 7 days or more

- Diarrhoea for 14 days or more

- Not able to drink or feed anything

- Unusually sleepy or unconscious

- Vomits everything

- Swelling of both feet

- Red on MUAC strap (severe acute malnutrition)



Age minimum: 2 Months
Age maximum: 59 Months
Gender: All
Health Condition(s) or Problem(s) studied
Pneumonia
Intervention(s)
Drug: Oral amoxicillin for CI pneumonia
Primary Outcome(s)
Number of CHWs appropriately managing chest indrawing pneumonia [Time Frame: At day of enrolment]
Number of participants with clinical treatment failure [Time Frame: By day 3 to 6]
Secondary Outcome(s)
Number of children with clinical relapse of pneumonia [Time Frame: Between day 7 and 15]
Number of children with chest indrawing pneumonia followed up by CHWs [Time Frame: By day 3]
Number of caregivers who find outpatient management of chest indrawing pneumonia acceptable for their child [Time Frame: 15 days after enrolment]
Secondary ID(s)
HQGMP1611887
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
World Health Organization
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history